Literature DB >> 4740124

[Studies on the disposition of the anticonvulsant clonazepam in the organisms of rat, dog, and man].

E Eschenhof.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4740124

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  10 in total

1.  Kinetics of biotransformation of clonazepam to its 7-amino metabolite in the monkey.

Authors:  A A Lai; B H Min; W A Garland; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

3.  Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration.

Authors:  A Berlin; H Dahlström
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

4.  Influence of phenobarbital on the disposition of clonazepam and antipyrine in the dog.

Authors:  I Bekersky; A C Maggio; V Mattaliano; H G Boxenbaum; D E Maynard; P D Cohn; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

5.  [Analytical data of flunitrazepam (rohypnol), a new benzodiazepine-derivative, in special consideration of its metabolites (author's transl)].

Authors:  S Ebel; H Schütz
Journal:  Z Rechtsmed       Date:  1978-05-29

6.  Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man.

Authors:  O Sjö; E F Hvidberg; J Naestoft; M Lund
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

7.  Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man.

Authors:  W Dieterle; J W Faigle; C Montigel; M Sulc; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

9.  Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1976-11       Impact factor: 9.546

10.  Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.

Authors:  Katalin Tóth; Gábor Csukly; Dávid Sirok; Ales Belic; Ádám Kiss; Edit Háfra; Máté Déri; Ádám Menus; István Bitter; Katalin Monostory
Journal:  Int J Neuropsychopharmacol       Date:  2016-12-30       Impact factor: 5.176
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.